BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33500319)

  • 21. Methylation and Gene Expression of
    Jedi M; Young GP; Pedersen SK; Symonds EL
    Clin Med Insights Oncol; 2018; 12():1179554918775064. PubMed ID: 29780264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer.
    Mitchell SM; Ho T; Brown GS; Baker RT; Thomas ML; McEvoy A; Xu ZZ; Ross JP; Lockett TJ; Young GP; LaPointe LC; Pedersen SK; Molloy PL
    Genes (Basel); 2016 Dec; 7(12):. PubMed ID: 27983717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction.
    Nassar FJ; Msheik ZS; Nasr RR; Temraz SN
    Clin Epigenetics; 2021 May; 13(1):111. PubMed ID: 34001239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
    Heiss JA; Brenner H
    Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer.
    Lange CP; Campan M; Hinoue T; Schmitz RF; van der Meulen-de Jong AE; Slingerland H; Kok PJ; van Dijk CM; Weisenberger DJ; Shen H; Tollenaar RA; Laird PW
    PLoS One; 2012; 7(11):e50266. PubMed ID: 23209692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
    Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
    Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
    Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
    J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT study.
    Brenne SS; Madsen PH; Pedersen IS; Hveem K; Skorpen F; Krarup HB; Giskeødegård GF; Laugsand EA
    Br J Cancer; 2023 Sep; 129(5):861-868. PubMed ID: 37438612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
    Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
    BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.
    Vedeld HM; Andresen K; Eilertsen IA; Nesbakken A; Seruca R; Gladhaug IP; Thiis-Evensen E; Rognum TO; Boberg KM; Lind GE
    Int J Cancer; 2015 Feb; 136(4):844-53. PubMed ID: 24948044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
    Herbst A; Vdovin N; Gacesa S; Ofner A; Philipp A; Nagel D; Holdt LM; Op den Winkel M; Heinemann V; Stieber P; Graeven U; Reinacher-Schick A; Arnold D; Ricard I; Mansmann U; Hegewisch-Becker S; Kolligs FT
    Int J Cancer; 2017 May; 140(9):2134-2144. PubMed ID: 28124380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
    Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
    Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
    Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
    Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.
    Church TR; Wandell M; Lofton-Day C; Mongin SJ; Burger M; Payne SR; Castaños-Vélez E; Blumenstein BA; Rösch T; Osborn N; Snover D; Day RW; Ransohoff DF;
    Gut; 2014 Feb; 63(2):317-25. PubMed ID: 23408352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare circulating microRNAs as biomarkers of colorectal neoplasia.
    Adams SV; Newcomb PA; Burnett-Hartman AN; Wurscher MA; Mandelson M; Upton MP; Zhu LC; Potter JD; Makar KW
    PLoS One; 2014; 9(10):e108668. PubMed ID: 25286412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer.
    Palanca-Ballester C; Hervas D; Villalba M; Valdes-Sanchez T; Garcia D; Alcoriza-Balaguer MI; Benet M; Martinez-Tomas R; Briones-Gomez A; Galbis-Caravajal J; Calvo A; Juan O; Lahoz A; Cases E; Sandoval J
    Clin Epigenetics; 2022 Sep; 14(1):116. PubMed ID: 36123616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation status as a biomarker of anti-epidermal growth factor receptor treatment for metastatic colorectal cancer.
    Ouchi K; Takahashi S; Yamada Y; Tsuji S; Tatsuno K; Takahashi H; Takahashi N; Takahashi M; Shimodaira H; Aburatani H; Ishioka C
    Cancer Sci; 2015 Dec; 106(12):1722-9. PubMed ID: 26426205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA.
    Benešová L; Hálková T; Ptáčková R; Semyakina A; Menclová K; Pudil J; Ryska M; Levý M; Šimša J; Pazdírek F; Hoch J; Blaha M; Minárik M
    World J Gastroenterol; 2019 Dec; 25(48):6939-6948. PubMed ID: 31908397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.